BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38580335)

  • 21. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
    Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
    Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
    Kandala PK; Srivastava SK
    BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
    Genovese T; Di Paola R; Catalano P; Li JH; Xu W; Massuda E; Caputi AP; Zhang J; Cuzzocrea S
    Crit Care Med; 2004 Jun; 32(6):1365-74. PubMed ID: 15187521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
    Ying W; Sevigny MB; Chen Y; Swanson RA
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.
    Andronikou C; Burdova K; Dibitetto D; Lieftink C; Malzer E; Kuiken HJ; Gogola E; Ray Chaudhuri A; Beijersbergen RL; Hanzlikova H; Jonkers J; Rottenberg S
    EMBO J; 2024 Mar; 43(6):1015-1042. PubMed ID: 38360994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
    Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
    Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
    Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
    Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
    Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
    Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing.
    Tulin A; Naumova NM; Menon AK; Spradling AC
    Genetics; 2006 Jan; 172(1):363-71. PubMed ID: 16219773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.
    Houl JH; Ye Z; Brosey CA; Balapiti-Modarage LPF; Namjoshi S; Bacolla A; Laverty D; Walker BL; Pourfarjam Y; Warden LS; Babu Chinnam N; Moiani D; Stegeman RA; Chen MK; Hung MC; Nagel ZD; Ellenberger T; Kim IK; Jones DE; Ahmed Z; Tainer JA
    Nat Commun; 2019 Dec; 10(1):5654. PubMed ID: 31827085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
    Zhou Y; Feng X; Koh DW
    Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.
    Frizzell KM; Gamble MJ; Berrocal JG; Zhang T; Krishnakumar R; Cen Y; Sauve AA; Kraus WL
    J Biol Chem; 2009 Dec; 284(49):33926-38. PubMed ID: 19812418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.
    Wilson AJ; Stubbs M; Liu P; Ruggeri B; Khabele D
    Gynecol Oncol; 2018 Jun; 149(3):575-584. PubMed ID: 29567272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of poly(ADP-ribose) glycohydrolase sensitizes lung cancer cells to radiation through the abrogation of DNA damage checkpoint.
    Nakadate Y; Kodera Y; Kitamura Y; Tachibana T; Tamura T; Koizumi F
    Biochem Biophys Res Commun; 2013 Nov; 441(4):793-8. PubMed ID: 24211580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
    Santiago-O'Farrill JM; Weroha SJ; Hou X; Oberg AL; Heinzen EP; Maurer MJ; Pang L; Rask P; Amaravadi RK; Becker SE; Romero I; Rubio MJ; Matias-Guiu X; Santacana M; Llombart-Cussac A; Poveda A; Lu Z; Bast RC
    Cancer; 2020 Feb; 126(4):894-907. PubMed ID: 31714594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib.
    James DI; Smith KM; Jordan AM; Fairweather EE; Griffiths LA; Hamilton NS; Hitchin JR; Hutton CP; Jones S; Kelly P; McGonagle AE; Small H; Stowell AI; Tucker J; Waddell ID; Waszkowycz B; Ogilvie DJ
    ACS Chem Biol; 2016 Nov; 11(11):3179-3190. PubMed ID: 27689388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
    Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
    Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer Cells.
    Sasaki Y; Fujimori H; Hozumi M; Onodera T; Nozaki T; Murakami Y; Ashizawa K; Inoue K; Koizumi F; Masutani M
    Cancer Res; 2019 Aug; 79(15):3851-3861. PubMed ID: 31142510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.
    Ding L; Kim HJ; Wang Q; Kearns M; Jiang T; Ohlson CE; Li BB; Xie S; Liu JF; Stover EH; Howitt BE; Bronson RT; Lazo S; Roberts TM; Freeman GJ; Konstantinopoulos PA; Matulonis UA; Zhao JJ
    Cell Rep; 2018 Dec; 25(11):2972-2980.e5. PubMed ID: 30540933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
    Min W; Cortes U; Herceg Z; Tong WM; Wang ZQ
    Carcinogenesis; 2010 Dec; 31(12):2058-65. PubMed ID: 20926829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.